As these drugs have an active ingredient of semaglutide, they been linked to an increased risk of blood clots
As the patent for semaglutidethe key ingredient behind globally popular injections like Ozempic and Wegovynears expiry in India, more than 50 new brands are preparing to enter the market, triggering what industry insiders are calling a Sema storm . The rush comes as the semaglutide patent expiry in India is expected around March 2026, opening the door for domestic pharmaceutical companies to manufacture and sell generic versions of the drug for the first time
If you or your loved one suffered side effects of health issues because of a weight-loss medication or GLP-1 drug, our law firm can help you pursue economic justice with a personal injury lawsuit
I grew up right here in Nashville, Tennesse
What Experts Really Think About Lemme's GLP-1 Supplement Don't get me wrong, do what makes you feel good
This includes planning for what happens before a GLP-1 is started, alongside the medication, and after a GLP-1 is stopped